uvDevelopment Corp. incorporates Ushio Care222 Filtered Far UV-C Module into uvSafelite™ Elevators

CYPRESS, Calif. - June 3, 2021 - PRLog -- Ushio America, Inc. ("Ushio"; www.ushio.com) announced the first-ever use of Care222® Filtered Far UV-C Excimer Lamp Modules in a system specifically designed for elevator disinfection*. uvDevelopment Corp. of Boston, MA (www.uvdevelopment.com) has designed a sanitizing engine system called uvSafeLite™, which will combine Care222 technology by Ushio, along with proprietary electronic controls, remote diagnostics, and system performance analysis. In partnership with Elevator Interior Design of Boston, MA (www.elevatorid.com), uvDevelopment Corp. has successfully incorporated the uvSafeLite system into the new uvSafeLite UV Sanitizing Light Columns for elevator applications.

The Care222® Filtered Far UV-C excimer lamps generate 222nm of Far UV-C light capable of inactivating viruses and bacteria in air and on indoor surfaces. The mercury-free Care222 excimer lamp modules produced by Ushio also feature a specially designed short-pass filter based on groundbreaking research and technology developed by Columbia University that blocks the longer UV wavelengths from the lamp that are harmful to humans. The result is a narrowband 222nm wavelength of UV light that can be used with people present to inactivate viruses and bacteria, effectively preventing them from replicating.

The uvSafeLite™ system incorporates Ushio's Care222 technology along with safe controls, optimization algorithms, automated diagnostics, performance reporting, and predictive maintenance features to automatically inactivate viruses and bacteria in targeted indoor spaces. The uvSafeLite Sanitizing Light Columns use patent-pending technology and packaging methods to seamlessly blend into both existing and new elevator cab designs.

Results from laboratory testing and clinical studies suggest that the filtered Far UV-C light emitted from the Care222 lamps can reduce pathogens in air and on surfaces without posing a health risk to human skin or eyes when used within established ACGIH guidelines. In contrast, possible acute and chronic damage to eyes and skin may result from the more generally employed 254nm wavelength used in traditional mercury-based germicidal lamps.

The first uvSafeLite installation is planned for a multi-elevator building located in Boston's Back Bay in May of 2021.

*All references to "disinfection" are referring generally to the reduction of pathogenic bioburden and are not intended to refer to any specific definition of the term as may be used for other purposes by the U.S. Food and Drug Administration or the U.S. Environmental Protection Agency.